Method for Improving Far Infrared Radiation Emission Rate of Cardiovascular Disease Prevention and Treatment Materials

Abstract

The invention relates to a method for improving the far-infrared emissivity of materials for preventing and treating cardiovascular diseases. The method includes putting the material storing far-infrared energy in the 6-14 micron band into a container, and then heating the container until the material can increase the far-infrared emissivity. Above the above temperature, after reaching the above temperature, continue to maintain an appropriate temperature, then cool the container, so that the material can increase the emissivity of far-infrared rays, and store far-infrared energy with a high emissivity of 0.88-0.99 to form cardiovascular disease prevention and treatment materials In this way, the 6-14 micron far-infrared rays stored in the above materials can produce a resonance effect with the molecules formed by the cell body, so as to improve the microcirculatory system, activate peripheral nerves, and prevent or delay the effects of cardiovascular diseases such as hypertension. Effect.

Description

technical field [0001] The invention relates to a method for increasing the far-infrared emissivity of materials for preventing and treating cardiovascular diseases, in particular to a method for heating, sintering and cooling a material storing far-infrared energy in the 6-14 micron band, so that it can store 0.88 ~0.99 far-infrared energy with a high emissivity rate, and through the far-infrared rays with a wavelength of 6-14 microns, it can improve the microcirculatory system, activate peripheral nerves, and prevent or delay cardiovascular diseases such as hypertension. Background technique [0002] Cardiovascular disease is a major threat to human health. According to the data released by the Department of Health, among the top ten causes of death among Chinese people, hypertension-related diseases account for five, among which cerebrovascular and heart diseases rank second and third respectively In the United States, cardiovascular disease is the number one cause of dea...

AI Technical Summary

Problems solved by technology

[0003] In general, the clinical mechanism of hypertension can be roughly divided into two categories: one is hypertension caused by a clear cause, such as: renal abnormalities (such as: nephritis complications, kidney stones, renal cortical atrophy, etc.), vascular Abnormalities (such as: aortic stenosis, renal artery stenosis) or endocrine abnormalities (such as: tumor or hyperfunction of organs), etc., if the cause of this type of hypertension can be removed and the blood pressure returns to normal, no medication is required; One type is hypertension caused by no clear cause. Patients with this type of hypertension often have a family history, so it is considered to be related to genetics. The symptoms of hypertension in this type of patients usually cannot be cured, although it can be adjusted through lifestyle adjustments and diet The change of habit can slow down the symptoms of hypertension, but basically all need the control of drugs; moreover, the drugs currently used to treat hypertension are chemically synthesized drugs, which have obvious side effects in clinical use. For example, diuretics are the most The common side effect is that it will reduce the potassium ion content in the patient's body, make the patient feel weak and tired or produce cramps, and it is more likely for diabetic patients to increase blood sugar; while beta-adrenergic blockers may cause insomnia, tired hands and feet, and slow heartbeat or asthma and other symptoms; alpha-adrenergic blockers may cause dizziness, rapid heartbeat, etc.; calcium ion blockers may cause palpitations, constipation, headache, or dizziness; angiotensin-converting enzyme blockers It may cause symptoms such as skin rash, loss of taste, dry cough, etc.; these side effects will cause certain physical damage or inconvenience to patients, and for long-term drug users, it is nothing less than a kind of torture

Images